Imaging AI in Pennsylvania

CurveBeam AI is a leader in cone beam CT (CBCT) imaging systems and AI-driven bone analysis software, specializing in weight-bearing CT (WBCT) for orthopedic and musculoskeletal applications. The company manufactures advanced imaging hardware and develops deep learning AI platforms for automated bone segmentation, microstructure analysis, and 3D deformity measurement to support surgical planning and clinical decision-making. Primary product lines include HiRise (weight-bearing cone beam CT system), InReach (high-resolution peripheral quantitative CT for bone microarchitecture), and Autometrics/CubeVue software (AI-assisted bone segmentation and analysis tools). CurveBeam AI serves orthopedic surgeons, podiatrists, hand surgeons, and trauma specialists in clinical practice and surgical centers. The company holds FDA clearance, CE marking, and Health Canada approval for its imaging systems, enabling point-of-care alternatives to conventional weight-bearing radiography and multi-location CT scanning. Core applications include joint deformity assessment, pre-operative surgical planning for joint replacement and reconstruction, trauma evaluation, and bone health screening. The company emphasizes sub-millimeter accuracy in measurement and rapid image acquisition in patient weight-bearing posture for clinically informed diagnosis.

iCat Solutions Ltd is a medical imaging software company specializing in advanced diagnostic visualization and analysis platforms for healthcare organizations and clinicians. The company develops 2D, 3D, and 4D imaging solutions incorporating volume rendering, multiplanar reconstruction (MPR), and specialized visualization tools designed to support clinical decision-making. iCat's software integrates with PACS (Picture Archiving and Communication Systems) and broader healthcare IT infrastructure to enable efficient clinical workflows and institutional collaboration. The platform emphasizes secure data handling and interoperability, allowing healthcare professionals to share imaging studies and collaborate across teams and institutional boundaries. Products incorporate professional-grade measurement, visualization, and analysis capabilities intended for diagnostic accuracy and clinical precision. The company targets healthcare organizations, imaging centers, and clinical departments requiring robust imaging software solutions. Regulatory compliance and integration with existing healthcare IT ecosystems are core platform design elements. iCat Solutions serves a global healthcare market with solutions tailored to evolving clinical and operational requirements.

Proscia, Inc. is an enterprise digital pathology and AI software platform company serving diagnostic laboratories, academic medical centers, health systems, pharmaceutical companies, contract research organizations (CROs), and biotech firms. The company develops and markets Concentriq, a purpose-built digital pathology platform offered in three modules: Concentriq LS for life sciences R&D and biomarker discovery; Concentriq AP for clinical laboratory digitization and workflow management; and Concentriq AP-Dx, which is FDA-cleared for primary diagnosis and supports both late-stage clinical trials and routine diagnostic operations. Proscia Aperture is a precision medicine analytics solution that converts pathology data into real-time, point-of-diagnosis patient insights for drug development and real-world evidence generation. The platform integrates AI analysis tools for pathologists and scientists, enabling automated image analysis, data harmonization across siloed sources, and collaborative research workflows. The company serves over 12,000 daily users across major diagnostic reference labs, 16 of the top 20 pharmaceutical companies, and leading academic institutions including Cleveland Clinic and PathGroup. Proscia holds FDA clearance for diagnostic applications and is recognized by KLAS as a leader in digital pathology. The company has raised significant capital to advance AI-driven pathology solutions and has been acknowledged by Fast Company and Fierce Biotech for innovation in AI and digital health.

Imalogix is a cloud-based healthcare technology platform specializing in AI-driven medical imaging analytics and compliance solutions for radiology departments. The company's end-to-end image management system transforms imaging data into actionable insights using proprietary deep learning algorithms and machine learning tools. Core capabilities include real-time radiation dose tracking and optimization, automated image quality assessment, technologist performance evaluation, protocol normalization, and one-click CMS compliance reporting. The vendor-agnostic platform integrates seamlessly with existing imaging systems and PACS infrastructure, enabling hospitals and healthcare providers to enhance workflow efficiency, reduce regulatory burden, and improve patient safety. Imalogix addresses critical compliance requirements including eCQM standards and radiation dose management mandates while eliminating manual protocol mapping and streamlining quality assurance processes.

inTRAvent Medical Partners LP is a medical device company specializing in intra-operative imaging and neuro-navigation systems for neurosurgical procedures. The company develops portable ultrasound-based navigation technology enhanced with artificial intelligence and trajectory guidance to improve safety and efficacy in neurosurgery. Their flagship product, SOLOPASS®, combines 2D and 3D ultrasound imaging with AI-driven guidance to provide real-time procedural localization and navigation at the bedside. Designed for neurosurgeons performing minimally invasive procedures, the technology enables enhanced visualization of anatomical structures and catheter placement guidance. The company is focused on translating advanced imaging and navigation capabilities into practical, user-friendly solutions for intraoperative use.